Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2023-12-12 | REGENERON PHARMACEUTICALS, INC. | McCourt Marion
(EVP Commercial) |
F | Common Stock | D | 5105 | $856.71 - $856.71 | $4,373,504 |
2023-12-05 | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J
(EVP Research) |
S | Common Stock | D | 6536 | $810.38 - $821.46 | $5,342,783 |
2023-12-04 | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J
(EVP Research) |
M | Common Stock | A | 20000 | $270.43 - $270.43 | $5,408,600 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |